Cargando…

Blood Clotting Factor VIII: From Evolution to Therapy

Recombinant blood clotting factor VIII is one of the most complex proteins for industrial manufacturing due to the low efficiency of its gene transcription, massive intracellular loss of its proprotein during post-translational processing, and the instability of the secreted protein. Improvement in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orlova, N. A., Kovnir, S. V., Vorobiev, I. I., Gabibov, A. G., Vorobiev, A. I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695351/ https://www.ncbi.nlm.nih.gov/pubmed/23819034

Ejemplares similares

Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification
por: Orlova, N. A., et al.
Publicado: (2012)

A Highly Productive CHO Cell Line Secreting Human Blood Clotting Factor IX
por: Kovnir, S. V., et al.
Publicado: (2018)

Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system
por: Orlova, Nadezhda A., et al.
Publicado: (2017)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

Improved elongation factor-1 alpha-based vectors for stable high-level expression of heterologous proteins in Chinese hamster ovary cells
por: Orlova, Nadezhda A, et al.
Publicado: (2014)

High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
por: Sinegubova, Maria V., et al.
Publicado: (2021)

High-level expression of biologically active human follicle stimulating hormone in the Chinese hamster ovary cell line by a pair of tricistronic and monocistronic vectors
por: Orlova, Nadezhda A., et al.
Publicado: (2019)

Clot stability as a determinant of effective factor VIII replacement in hemophilia A
por: Leong, Lilley, et al.
Publicado: (2017)

Promoter from Chinese hamster elongation factor-1a gene and Epstein-Barr virus terminal repeats concatemer fragment maintain stable high-level expression of recombinant proteins
por: Sinegubova, Maria V., et al.
Publicado: (2023)

Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
por: Demers, Melanie, et al.
Publicado: (2022)

Natural and engineered mediators of desiccation tolerance stabilize Human Blood Clotting Factor VIII in a dry state
por: Packebush, Maxwell H., et al.
Publicado: (2023)

Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers
por: Ketteler, Carolin, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate
por: Matsumoto, Takeshi, et al.
Publicado: (2023)

Blood clot contraction: Mechanisms, pathophysiology, and disease
por: Litvinov, Rustem I., et al.
Publicado: (2022)

A modular assembly cloning technique (aided by the BIOF software tool) for seamless and error-free assembly of long DNA fragments
por: Orlova, Nadezhda A, et al.
Publicado: (2012)

Blood Clotting and Allied Problems
por: Vaughn, V. C.
Publicado: (1950)

Blood Clotting Enzymology
por: Milstone, J. Haskell
Publicado: (1967)

Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A
por: Csencsits-Smith, Keri, et al.
Publicado: (2015)

Blood Clotting and Allied Problems
Publicado: (1952)

Blood Clotting and Allied Problems
Publicado: (1953)

Rupture of blood clots: Mechanics and pathophysiology
por: Tutwiler, Valerie, et al.
Publicado: (2020)

Effects of Hyperhomocysteinemia on the Platelet-Driven Contraction of Blood Clots
por: Litvinov, Rustem I., et al.
Publicado: (2021)

Quantitative structural mechanobiology of platelet-driven blood clot contraction
por: Kim, Oleg V., et al.
Publicado: (2017)

Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism
por: Evtugina, Natalia G., et al.
Publicado: (2020)

Antigenic properties of the SARS-CoV-2 nucleoprotein are altered by the RNA admixture
por: Kolesov, Denis E., et al.
Publicado: (2022)

Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts
por: Zhalyalov, Ansar S., et al.
Publicado: (2017)

Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study
por: Schütte, Lisette M, et al.
Publicado: (2019)

Activated Monocytes Enhance Platelet-Driven Contraction of Blood Clots via Tissue Factor Expression
por: Peshkova, Alina D., et al.
Publicado: (2017)

Clot‐targeted magnetic hyperthermia permeabilizes blood clots to make them more susceptible to thrombolysis
por: Cabrera, David, et al.
Publicado: (2022)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
por: Calvert, Peter, et al.
Publicado: (2021)

Deportment of Blood-Clot and Blood-Deposits in Vessels and Tissues
por: Ramsey, Frank A.
Publicado: (1874)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
por: Preijers, Tim, et al.
Publicado: (2020)

The History of Clotting Factor Concentrates Pharmacokinetics
por: Morfini, Massimo
Publicado: (2017)

Acquired Factor VIII Inhibitor Presenting as Occult GI Bleeding
por: Pacheco Cano, Carlos I., et al.
Publicado: (2018)

Accelerated Spatial Fibrin Growth and Impaired Contraction of Blood Clots in Patients with Rheumatoid Arthritis
por: Peshkova, Alina D., et al.
Publicado: (2020)

EFFECT OF BILE ON THE CLOTTING TIME OF BLOOD
por: Haessler, Herbert, et al.
Publicado: (1919)

THE ACTION OF CHLORINATED ANTISEPTICS ON BLOOD CLOT
por: Taylor, Herbert D., et al.
Publicado: (1919)

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
por: Nguyen, G. N., et al.
Publicado: (2016)

Red Blood Cells are Appropriate Carrier for Coagulation Factor VIII
por: Sayyadipour, Fatemeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eqrci3tairivjm8austg8l5h39